Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 136,601 |
|
|||||
| News | - | ||||||
| Day High | 1.48 | Low High |
|||||
| Day Low | 1.39 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Cel Sci Corporation New | CVM | AMEX | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.02 | 1.38% | 1.47 | 18:18:08 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.47 | 1.39 | 1.48 | 1.44 | 1.45 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 874 | 136,601 | US$ 1.43 | US$ 195,579 | - | 1.04 - 3.23 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 19:00:00 | 418 | US$ 1.44 | USD |
Cel Sci Corporation New Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 74.21M | 52.26M | - | 0 | -32.37M | -0.62 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Cel Sci News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CVM Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.54 | 1.57 | 1.39 | 1.50 | 138,343 | -0.07 | -4.55% |
| 1 Month | 1.91 | 1.92 | 1.39 | 1.65 | 167,707 | -0.44 | -23.04% |
| 3 Months | 2.71 | 3.08 | 1.39 | 2.10 | 308,983 | -1.24 | -45.76% |
| 6 Months | 1.38 | 3.23 | 1.17 | 2.30 | 477,373 | 0.09 | 6.52% |
| 1 Year | 2.35 | 3.23 | 1.04 | 1.93 | 549,355 | -0.88 | -37.45% |
| 3 Years | 23.52 | 27.84 | 1.04 | 6.45 | 724,968 | -22.05 | -93.75% |
| 5 Years | 6.60 | 40.91 | 1.04 | 9.27 | 760,053 | -5.13 | -77.73% |
Cel Sci Description
| CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The company is focused on activating the immune system to fight cancer and infectious diseases. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia. |
